top of page
logo_POCRB.png
Logo_POC.png

A Randomized Trial of Closed Reduction without Analgesia, Intramuscular Nsaids, and Intravenous Sedation-Analgesia For Acute Anterior Shoulder islocation

Federico P. Aquino III, MD, Jason Paul Santiago, MD

1st Place - Podium Presentation: 25th Resident’s Research Forum,

Philippine Orthopedic Center, February 18, 2022


1st Place - Podium Presentation: 2022 Interdepartmental Research Paper Contest   Philippine Orthopedic Center, December 14, 2022


Date of Completion: March 27, 2022

ABSTRACT


INTRODUCTION

The glenohumeral   joint is a highly movable, unstable joint prone to dislocation.


AIM

To evaluate  the clinical outcomes of closed reduction   of acute anterior shoulder dislocation without analgesia, intramuscular NSAIDs (IM NSAIDs), and intravenous sedation with analgesia (IVSA),   in terms   of pain reduction, reduction time, ER stay duration, complications,   and disability severity.


METHODS

Sixty patients with AASD aged 15 to 35 were randomly   distributed into three groups for reduction without analgesia (Group 1), IM   NSAIDs (Group 2), and IVSA (Group 3). Senior orthopedic residents unaware of   patients’ treatment groups measured clinical outcomes. Statistical analysis   utilized paired t-test, one-way analysis of variance (ANOVA), and chi-square   test at 0.05 significance level.


RESULTS

The three groups were comparable in demographic   profile, pain scores at baseline and one-hour post- reduction, and disability   severity (p>0.05). However, IVSA hada significantly higherquantity of painreduction (p=0.0003), shorter reduction time (p=0.0001), and more prolonged ER stay (p=0.0001). There were no complications observed.


CONCLUSION

The similar pain-relieving effects of no   analgesia, IM NSAIDs, and IVSA  suggests their acceptable use for AASD treatment. Patients with severe pain may benefit from IVSA because it affords   more pain relief and a faster reduction time.

View Full Paper
bottom of page